According to CMS , the program will run from July 1, 2026, through December 31, 2027, and eligible beneficiaries will pay a $50 copay for a monthly supply
The USA will be the largest country in the GLP-1 receptor agonist market in 2030, valued at $80,345 million
Hair loss is only rampant today because modern toxins and stress keep the scalp in a hostile environment so DHT's damage hits way harder
When combined with tirzepatide, which is typically injected once weekly on a consistent day, there is no specific timing interaction between the two
This conversation should include your specific nursing duration timeline, infant age, overall health objectives, and alternative weight management strategies